news
09-14-2021, 10:21 AM
https://i.cbc.ca/1.5888885.1611698784!/cpImage/httpImage/image.jpg_gen/derivatives/16x9_460/covid-vaccine-providence-20210126.jpg Emergent BioSolutions Inc. signed a five-year agreement with Calgary-based biotechnology company Providence Therapeutics to develop and manufacture its COVID-19 vaccine candidate for about $90 million.
More... (http://action.news/newstempcb.php?article=/news/canada/calgary/providence-emergent-biosolutions-calgary-winnipeg-covid-1.6174901)
From http://start.westnet.ca News
News Provided By
WestNet Wireless Internet
More... (http://action.news/newstempcb.php?article=/news/canada/calgary/providence-emergent-biosolutions-calgary-winnipeg-covid-1.6174901)
From http://start.westnet.ca News
News Provided By
WestNet Wireless Internet